Aptamer Structural Motifs and Engineering Strategies for Improved Affinity and Stability

4 Aptamer

Aptamer Structural Motifs and Engineering Strategies for Improved Affinity and Stability Introduction Aptamers are short single-stranded DNA or RNA molecules that fold into defined three-dimensional structures and recognize targets with high affinity and specificity. Generated through SELEX (Systematic Evolution of Ligands by Exponential Enrichment), aptamers offer advantages including chemical synthesis, precise modification, small molecular size, …

Read More

Hybridoma vs Phage Display: Choosing the Right Platform for Monoclonal Antibody Discovery

1 Antibody

Hybridoma vs Phage Display: Choosing the Right Platform for Monoclonal Antibody Discovery Introduction Monoclonal antibody discovery relies mainly on two established platforms: hybridoma technology and display-based antibody selection, including phage display and yeast display. Both approaches have contributed significantly to research and therapeutic antibody development, but their advantages depend on target properties, project timelines, and …

Read More

Literature Analysis (Science) | Bispecific Antibodies Enable Safer Cancer Therapy Through Tumor-Selective Targeting Strategies

1 Antibody

Bispecific Antibodies Enable Safer Cancer Therapy Through Tumor-Selective Targeting Strategies Introduction Many cancer therapies fail to achieve their full potential because the molecular targets driving tumor growth are also essential for normal tissue function. Blocking pathways such as Wnt, EGFR, or FGFR1 can effectively inhibit tumors but often causes severe toxicity in healthy organs. A …

Read More

Optimizing scFv Linker Design to Improve Antibody Stability and Binding Performance

1 Antibody

Optimizing scFv Linker Design to Improve Antibody Stability and Binding Performance Introduction Single-chain variable fragments (scFv antibodies) are widely used in antibody engineering due to their compact size, efficient expression, and compatibility with applications such as bispecific antibodies, CAR-T cell therapies, and fusion proteins. An scFv consists of VH and VL antibody domains connected by …

Read More

Complement C5 Targeting Strategies: Mechanisms and Therapeutic Applications

2 Protein

Complement C5 Targeting Strategies: Mechanisms and Therapeutic Applications Introduction The complement system is a critical component of innate immunity, responsible for pathogen defense, immune regulation, and elimination of abnormal cells. As the terminal effector molecule of the complement cascade, Complement C5 plays a central role by generating two key fragments: C5a, a powerful inflammatory mediator, …

Read More

Optimizing SELEX Stringency Conditions for High-Affinity Aptamer Selection

4 Aptamer

Optimizing SELEX Stringency Conditions for High-Affinity Aptamer Selection Introduction SELEX (Systematic Evolution of Ligands by Exponential Enrichment) is the most widely used platform for identifying high-affinity aptamers from large nucleic acid libraries. Through repeated cycles of binding, separation, and amplification, SELEX enables the enrichment of DNA aptamers and RNA aptamers with strong target recognition. A …

Read More

Downstream Purification Strategies for High-Quality VHH Antibody Production

1 Antibody

Downstream Purification Strategies for High-Quality VHH Antibody Production Introduction VHH antibodies, also known as nanobodies, are the smallest antibody fragments (~12–15 kDa) and have gained increasing attention due to their compact size, high stability, and ability to access unique epitopes. Following VHH discovery and VHH phage display screening, successful candidates require optimized expression and purification …

Read More